News from celsion corporation A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 01, 2015, 08:00 ET

Celsion Corporation to Present at Cantor Fitzgerald's Inaugural Healthcare Conference on July 8, 2015

 Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced that Michael H. Tardugno, Chairman, President and...

Jun 01, 2015, 08:00 ET

Celsion Presents GEN-1 Immunotherapy Phase 1b Results in Recurrent Ovarian Cancer at ASCO 2015

Celsion Corporation (NASDAQ: CLSN), a fully integrated oncology drug development company, announced the presentation of clinical results from its...

May 28, 2015, 08:45 ET

Celsion Corporation Announces $8 Million At-The-Market Registered Direct Offering

Celsion Corporation (the "Company") (NASDAQ: CLSN) today announced that it has received commitments from two institutional healthcare investors to...

May 21, 2015, 08:00 ET

Celsion Announces Potent, Durable Preclinical Lung Expression Data for Its Novel TheraSilence™ RNA Program

 Celsion Corporation (NASDAQ: CLSN), a fully-integrated oncology company focused on the development of a portfolio of innovative cancer...

May 15, 2015, 08:00 ET

Celsion Announces Publication of Preclinical Data Demonstrating Lung Specific Delivery of microRNA-145 Inhibitor Using Its Novel TheraSilence™ Platform

Celsion Corporation (NASDAQ:CLSN), a fully-integrated oncology company focused on the development of a portfolio of innovative cancer...

May 13, 2015, 17:01 ET

Celsion Corporation Announces ASCO 2015 GEN-1 Immunotherapy Phase 1b Results in Ovarian Cancer Presentation

 Celsion Corporation (NASDAQ: CLSN), a fully integrated oncology drug development company, today announced that results from its Phase Ib trial...

May 12, 2015, 08:00 ET

Celsion Corporation Reports First Quarter 2015 Financial Results and Provides Business Update

Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced financial results for the quarter ended March 31, 2015...

May 05, 2015, 08:00 ET

Celsion Corporation to Hold First Quarter 2015 Financial Results Conference Call on Tuesday, May 12, 2015

 Celsion Corporation (NASDAQ: CLSN) announced today that the Company will host a conference call to discuss its first quarter 2015 financial...

Apr 29, 2015, 08:00 ET

Celsion Expands Clinical Development Plan for GEN-1 IL-12 Immunotherapy Program in Ovarian Cancer

 Celsion Corporation (NASDAQ: CLSN), a fully-integrated oncology company focused on the development of a portfolio of innovative cancer...

Apr 27, 2015, 08:00 ET

Celsion Corporation Announces Appointment of Harriet Shelare to Director, Communications

 Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced the appointment of Harriet Shelare as Director,...

Apr 15, 2015, 08:00 ET

Celsion Announces Positive Interim Data from its Phase 2 DIGNITY Study in Breast Cancer

 Celsion Corporation (NASDAQ: CLSN) announced today positive interim data from its ongoing open-label Phase 2 DIGNITY Trial of ThermoDox®...

Mar 12, 2015, 08:00 ET

Celsion Corporation Reports Year End 2014 Financial Results and Provides Business Update

 Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced financial results for the year ended December 31,...

Mar 05, 2015, 08:00 ET

Celsion Corporation to Hold Year-End 2014 Financial Results Conference Call on Thursday, March 12, 2015

 Celsion Corporation (NASDAQ: CLSN) announced today that the Company will host a conference call to discuss year-end 2014 financial results and...

Feb 23, 2015, 08:00 ET

Celsion Announces Updated Overall Survival Data from HEAT Study of ThermoDox® in Primary Liver Cancer

Celsion Corporation (NASDAQ: CLSN) today announced updated results from its retrospective analysis of the Company's 701-patient HEAT Study of...

Feb 20, 2015, 08:00 ET

Celsion Corporation Presents Clinical and Preclinical Data for GEN-1 IL-12 Immunotherapy in Ovarian Cancer at the Molecular Medicine TRI-Conference

 Celsion Corporation (NASDAQ: CLSN), a fully-integrated oncology company focused on the development of a high potential portfolio of innovative...

Jan 21, 2015, 10:07 ET

Celsion Corporation y myTomorrows se asocian para presentar el programa de acceso primario ThermoDox® en Europa

- Celsion Corporation y myTomorrows se asocian para presentar el programa de acceso primario ThermoDox® en Europa para los pacientes con...

Jan 20, 2015, 08:00 ET

Celsion Corporation and myTomorrows Partner to Introduce ThermoDox® Early Access Program in Europe for Patients with Recurrent Chest Wall Breast Cancer

Celsion Corporation (NASDAQ:CLSN), a fully-integrated oncology company focused on the development of a portfolio of innovative cancer treatments,...

Jan 20, 2015, 08:00 ET

Celsion Corporation und myTomorrows rufen in Europa gemeinsames ThermoDox® Early Access-Programm für Patienten mit rezidivierendem Brustkrebs an der Brustwand ins Leben

Celsion Corporation (NASDAQ:CLSN), ein vollintegriertes Onkologie-Unternehmen, das sich auf die Entwicklung eines Portfolios an innovativen...

Jan 20, 2015, 08:00 ET
Jan 06, 2015, 08:00 ET

Celsion Corporation Submits DNA-based Immunotherapy Clinical Protocol to the FDA as Part of a First Line Treatment for Ovarian Cancer

Celsion Corporation (Celsion) (NASDAQ:CLSN), a fully-integrated oncology company focused on the development of a portfolio of innovative cancer...